Teva Pharmaceutical Industries Ltd
Close on Nov 17, 2026Market cap $49.66BP/E 71.0Yield –
Teva Pharmaceutical Industries Proceeds from Sale of Businesses and Long-Lived Assets by Quarter
Proceeds from Sale of Businesses and Long-Lived Assets ($M)
Teva Pharmaceutical Industries Proceeds from Sale of Businesses and Long-Lived Assets: $47M in Q3 2026, up 487.5% from a year earlier.
Where the Q3 2026 figure comes from
“|| Proceeds from sale of businesses and long-lived assets, net | 47 | 8”
Source: SEC Form 10-Q (0000818686-26-000006) ↗
Reported in SEC Form 10-K / Form 10-Q / Form 8-K Earnings Releases.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Teva Pharmaceutical Industries Proceeds from Sale of Businesses and Long-Lived Assets ($M), quarterly Q1 2018–Q3 2026 [Data set]. Compiled from Teva Pharmaceutical Industries SEC filings and investor materials. https://stockdatahq.com/stocks/teva/kpis/fcf-divest-proceeds
See every metric in the Teva Pharmaceutical Industries KPI table. Data updated Nov 10, 2026.
See a number that looks wrong?